Latest Financial Health News

Amplia Therapeutics reports encouraging clinical progress for its pancreatic cancer drug narmafotinib, with a 35% confirmed response rate in the ACCENT trial and FDA support for dose optimisation. The company also uplisted to the US OTCQB market and secured a key patent extending protection to 2040.

GreenX Metals has confirmed the validity of historical copper grades at its Tannenberg project in Germany through modern assays, while securing A$13.6 million in fresh capital to advance exploration. The company also won a key legal battle affirming its right to substantial compensation from Poland.

Forrestania Resources Limited has made significant strides in its expansion strategy during Q2 2025/2026, marked by the acquisition of Kula Gold Ltd, a substantial capital raise, and multiple project acquisitions across Western Australia.

Mustera Property Group reports strong sales momentum with $15.05 million contracted at its Verse on McCabe development, alongside a $3 million settlement at Forbes Residences, setting the stage for construction to begin in Q2 2026.

Far Northern Resources has resumed its Phase 2 drilling program at the Bridge Creek project in the Northern Territory, aiming to expand its gold resource. The company maintains a solid cash position, supporting ongoing exploration activities.

Decidr AI Industries has solidified its position in the agentic AI market by completing strategic acquisitions and launching its DecidrOS platform, achieving a 60% revenue increase in the December quarter.

Australian Agricultural Projects Ltd reports steady orchard health and harvest expectations amid rising water prices, while strengthening its asset base and maintaining robust cashflow in the December 2025 quarter.

Orbital Corporation Ltd reports a stronger cash position and a strategic new order for its 350cc heavy fuel engine, signalling growth in both military and commercial UAV markets.

Red Hill Minerals reported a solid $7.8 million royalty from its Onslow Iron Project and unveiled promising exploration results across its Broken Hill and Anabama projects, reinforcing its growth trajectory.

Moonlight Resources has kicked off its ASX debut with promising gold drilling results at its Clermont project, confirming significant mineralisation and setting the stage for accelerated exploration.

Immutep Limited has entered a strategic collaboration with Dr. Reddy’s, receiving a A$30 million upfront payment and potential milestones up to A$528 million, while reporting promising clinical progress across multiple cancer immunotherapy trials.

Hawthorn Resources has reported exceptional high-grade drilling results at its Anglo Saxon Gold Project, underpinning a robust updated resource estimate and advancing plans for open pit mining. The company’s strong cash position supports ongoing development amid record gold prices.